More on NPCE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.14 |
|
|||
| Open | $12.76 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $13.07 | ||||
| Day Low | $12.76 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 69,068 | ||||
- Form 4 NeuroPace Inc For: Sep 24 Filed by: Morrell Martha
- Form 4 NeuroPace Inc For: Sep 20 Filed by: Williams Patrick F.
- KeyBanc Starts NeuroPace Inc (NPCE) at Overweight
- Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
- Form 4 NeuroPace Inc For: Aug 27 Filed by: Becker Joel
- Form 4 NeuroPace Inc For: Aug 27 Filed by: Morrell Martha
- NeuroPace (NPCE) Reiterated at Overweight by Cantor Fitzgerald on Commercial Momentum
- Form SCHEDULE 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
- NeuroPace (NPCE) Tops Q2 EPS by 3c
- Form 10-Q NeuroPace Inc For: Jun 30
Entities mentioned with NPCE
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- JPMorgan | View Related Stories »
- 13G | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Show More...
